Ameren prices forward stock sale at $91.885 per share, settlement by January 15, 2027
Ameren entered into forward sale agreements with four banks on May 12 and May 13, 2025, tied to a registered public offering of its common stock. The underwriters exercised their 30-day option in full on May 13, and the shares were sold on May 14, 2025. The filing does not state the number of shares, but the initial forward sale price is $91.885 per share and Ameren can choose when to settle, on or before January 15, 2027, which could lead to future share issuance.
Key points
- Initial forward sale price is $91.885 per share, the price the underwriters agreed to pay for the offered shares.
- Ameren may settle physically, in cash or by net share settlement, on a date it chooses on or before January 15, 2027.
- The underwriters exercised their 30-day option in full on May 13, 2025; the shares were sold on May 14, 2025.
- The offering was made under Form S-3 (File No. 333-274977) and a prospectus supplement dated May 12, 2025.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:10 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 14, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.